Ascendis Pharma A ASND
NASDAQ ASND
$227.31 -0.52 (-0.23%)
At close: Oct 1, 2026 · 4:00 PM EDT

Ascendis Pharma A (ASND) Cash from Financing Activities (2014 - 2026)

Updated

Ascendis Pharma A (ASND) recorded Cash from Financing Activities of -$53.61 million in the quarter ended Jun 30, 2026, compared with $7.9 million a year earlier.

Analysis

Ascendis Pharma A (ASND) Cash from Financing Activities (2014 - 2026) Analysis & Trends

On a TTM basis, Ascendis Pharma A's Cash from Financing Activities came in at -$19.41 million as of Jun 30, 2026; for the year ended Dec 31, 2025, it was $62.38 million, down 87.0% from the prior year.

  • Annual Cash from Financing Activities has a five-year compound annual growth rate of -38.7% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Cash from Financing Activities came in at $480.48 million in the year ended Dec 31, 2024 (+230.8%), $145.27 million in the year ended Dec 31, 2023 (-65.3%), $418.18 million in the year ended Dec 31, 2022 (+4.0%) and $401.98 million in the year ended Dec 31, 2021 (-44.1%).
  • The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Cash from Financing Activities since the quarter ended Dec 31, 2020.
  • Per Business Quant, the preceding three quarters came in at -$43.12 million (quarter ended Mar 31, 2026), $31.9 million (quarter ended Dec 31, 2025) and $45.42 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Ascendis Pharma A 14.12 Bn 10.37 Bn 362.22 Mn -53.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -53.61 Mn
Mar 31, 2026 -43.12 Mn
Dec 31, 2025 31.90 Mn
Sep 30, 2025 45.42 Mn
Jun 30, 2025 7.90 Mn
Mar 31, 2025 -18.96 Mn
Dec 31, 2024 92,967.80
Sep 30, 2024 469.90 Mn
Jun 30, 2024 -2.64 Mn
Mar 31, 2024 20.01 Mn
Dec 31, 2023 -6.51 Mn
Sep 30, 2023 156.06 Mn
Jun 30, 2023 -2.51 Mn
Mar 31, 2023 -753,485.96
Dec 31, 2022 1.38 Mn
Sep 30, 2022 -76,628.85
Jun 30, 2022 -2.38 Mn
Mar 31, 2022 446.39 Mn
Dec 31, 2021 -23.60 Mn
Sep 30, 2021 437.05 Mn
API Access

Ascendis Pharma A Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ASND&period=max&api_key=YOUR_API_KEY